The Australian biotechnology company develops high-purity seaweed extracts for human health.
Marinova Pty Ltd. (Tasmania, Australia) won an award in Global Health & Pharma Magazine’s 2023 International Life Sciences Awards in the category of Health & Wellness Ingredient Innovator of the Year. The Australian biotechnology company develops high-purity seaweed extracts for human health, particularly fucoidan compounds, derived from select brown seaweed species and containing highly bioactive polysaccharides.
The company describes its Maritech fucoidan extracts, suited for nutritional supplements, functional foods/beverages, skincare products, and animal health products, as “the world’s only high-purity, certified-organic fucoidan extracts with global regulatory acceptance.”
In a press release, Marinova’s CEO Paul Garrott, stated, “The unrivaled quality and efficacy of Maritech organic fucoidans is based on two decades of rigorous scientific investigation and the development of an advanced proprietary extraction process.”